Copenhagen and Oslo, 12th October 2012, 2012-10-12 16:06 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that Trans Nova Investments Limited, the largest shareholder in Affitech A/S with 76,78% ownership has agreed to extend the due date for the Euro 1.5 million short term loan provided in July 2012 and paid to Affitech in three tranches in July, August and September 2012 . The due date has been extended from 16th October, 2012 until 16th January, 2013. The other conditions for the loan remain unchanged.
